| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f4ff2e1e147b06eed3e237ecdc2c52a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_018aa1b7e21b5f0fdecce5402065b49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5814606dfa17b3f3ba75bd976b1980b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bff18d714c119b3b37a30acc3e217bc7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| filingDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58bec64ab9a4d75cd26a99e7df4ce45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1e4dc3461533c0484ced04b28b96aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f24f85252340cdfcd9b4e7369e8e568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54f36b259ffaf14e9fb69ad466ab6911 |
| publicationDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006093647-A1 |
| titleOfInvention |
Multiple layer coating composition |
| abstract |
A multiple layer coating for application upon surfaces of an implantable medical device, a first layer of such coating includes an anti-thrombogenic factor and a second layer of such coating includes a hyperplasia inhibiting factor that is releasably contained therein. The hyperplasia inhibiting factor is controllably released from the multiple layer coating over a predetermined period of time upon implantation of the medical device in vivo. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007090505-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016047781-A1 |
| priorityDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |